2019
DOI: 10.1016/j.fitote.2018.12.023
|View full text |Cite
|
Sign up to set email alerts
|

New compounds of Siolmatra brasiliensis and inhibition of in vitro protein glycation damage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 37 publications
0
3
0
Order By: Relevance
“…The in vitro model system of protein glycation was applied according to dos Santos et al 11 and Motta et al 12 Bovine serum albumin (BSA, 10 mg/mL; ≥96%, A6003, Sigma-Aldrich, USA) was incubated with 0.5 M glucose (≥97%, G5250, Sigma-Aldrich, USA) in 0.1 M phosphate buffer (pH 7.4) containing 0.02% sodium azide, at 37°C for 30 days. Moreover, BSA (without glucose) and BSA + glucose were incubated in the absence or presence of aminoguanidine (1 mM, prototype therapeutic agent with anti-AGE activity; 97%, 109266, Sigma-Aldrich, USA) or metformin (1 mM; 99.56% purity, Gemini Indústria de Insumos Farmacêuticos Ltda, Brazil), and in the absence or presence of quercetin (100 µM, 50 µM, 12.5 µM; ≥ 95%, Q4951, Sigma-Aldrich, USA) or rutin (100 µM, 50 µM, 12.5 µM; ≥ 94%, R5143, Sigma-Aldrich, USA).…”
Section: In Vitro Model System Of Protein Glycationmentioning
confidence: 99%
See 1 more Smart Citation
“…The in vitro model system of protein glycation was applied according to dos Santos et al 11 and Motta et al 12 Bovine serum albumin (BSA, 10 mg/mL; ≥96%, A6003, Sigma-Aldrich, USA) was incubated with 0.5 M glucose (≥97%, G5250, Sigma-Aldrich, USA) in 0.1 M phosphate buffer (pH 7.4) containing 0.02% sodium azide, at 37°C for 30 days. Moreover, BSA (without glucose) and BSA + glucose were incubated in the absence or presence of aminoguanidine (1 mM, prototype therapeutic agent with anti-AGE activity; 97%, 109266, Sigma-Aldrich, USA) or metformin (1 mM; 99.56% purity, Gemini Indústria de Insumos Farmacêuticos Ltda, Brazil), and in the absence or presence of quercetin (100 µM, 50 µM, 12.5 µM; ≥ 95%, Q4951, Sigma-Aldrich, USA) or rutin (100 µM, 50 µM, 12.5 µM; ≥ 94%, R5143, Sigma-Aldrich, USA).…”
Section: In Vitro Model System Of Protein Glycationmentioning
confidence: 99%
“…Protein crosslinking was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), as described by Santos et al 11 and Motta et al 12 Reducing buffer (62.5 mM Tris-HCl, 10% glycerol, 2% SDS, 33.2 mM dithiothreitol, 0.01% bromophenol blue; pH 6.8) was added to the incubation samples. Samples containing 5 μg of protein were subjected to SDS-PAGE in 10% polyacrylamide gels.…”
Section: Protein Crosslink Formationmentioning
confidence: 99%
“…Compound 1 , also known as sakuranetin, was first isolated from the Japanese cherry tree Puneus pseudo-cerrasus ( Asahina, 1908 ) in the early 20 th century, while compound 2 was first identified as a constituent of South-American Tessaria dodoniefolia in 1973 ( Kavka et al., 1973 ). Most recently, 1 and 2 have been reported as constituents of Siolnatria brasilensis ( dos Santos et al., 2019 ), Rhus retinorrhoea ( Mossa et al., 1996 ) and Arteminia halodendron ( Sun et al., 2019 ).…”
Section: Introductionmentioning
confidence: 99%